Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Royalty Pharma (RPRX) has a market cap of $18.64 billion USD. According to our data, Royalty Pharma is ranked No.970 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $18.64 B |
64.43%
|
| Dec 31, 2024 | $11.33 B |
-6.36%
|
| Dec 29, 2023 | $12.10 B |
-27.08%
|
| Dec 30, 2022 | $16.60 B |
0.99%
|
| Dec 31, 2021 | $16.44 B |
-19.09%
|
| Dec 31, 2020 | $20.32 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
USA
|
 Moderna
MRNA
|
$10.14 B |
-0.001 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
USA
|
 Incyte
INCY
|
$11.31 B |
0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
USA
|
 Jazz Pharmaceuticals
JAZZ
|
$6.25 B |
0.000 M
|
Ireland
|
|
Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
USA
|
| Market Cap | = | RPRX Stock Price | * | RPRX Shares Outstanding |
| = | $32.45 | * | 0.43 B | |
| = | $18.64 B |